When low sexual desire doesn’t respond to addressing the obvious causes, some men look for additional options — and bremelanotide, also known as PT-141, often comes up. Unlike medications that work on blood flow, bremelanotide acts on the brain’s desire pathways. It’s a genuinely different approach, but it comes with an important caveat: it’s FDA-approved for women, not men, so its use in men is off-label. Dr. Justin Houman believes that’s exactly the kind of thing a patient should understand clearly before deciding.
Dr. Justin Houman is a board-certified urologist, Fellow of the American College of Surgeons, and Assistant Professor of Urology at Cedars-Sinai Medical Center, fellowship-trained in male reproductive and sexual medicine at UCLA. A member of the Sexual Medicine Society of North America, he stays current on the medications shaping men’s sexual health and is careful to distinguish what’s proven from what’s promising. His perspective has been featured in national media including Men’s Health, and he brings that same evidence-first honesty to off-label options like bremelanotide.
I had an excellent experience with Dr. Justin Houman, who is truly an expert in male fertility. He took the time to listen carefully and explain all the available options in a way that was easy to understand. His approach is compassionate, professional, and very thorough. I felt confident knowing I was in the care of someone highly specialized in men’s reproductive health. If you are looking for a knowledgeable and caring physician to help with male fertility concerns, I highly recommend Dr. Houman.
What Is Bremelanotide (PT-141)?
Bremelanotide, sold under the brand name Vyleesi, is a melanocortin receptor agonist — a medication that activates receptors in the brain and nervous system involved in sexual desire. Rather than acting on the genitals or blood flow, it works centrally, influencing the brain pathways that drive interest in sex. It is FDA-approved specifically to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.
How Bremelanotide Works for Men
In men, bremelanotide is used off-label with the goal of increasing sexual desire through that same central, brain-based mechanism. This is what distinguishes it from medications like sildenafil or tadalafil, which improve blood flow to produce an erection but do nothing for desire itself. For a man whose primary issue is low libido rather than erectile function, that difference is the entire appeal — though it’s important to understand that this use in men falls outside the medication’s FDA approval.
What the Evidence and FDA Status Say
Honesty here matters. Bremelanotide is FDA-approved only for premenopausal women with HSDD; it is not approved for men, and it is not intended to enhance sexual performance. Crucially, dedicated clinical trials establishing its safety and effectiveness in men have not been conducted, which means the risks and benefits for men are not well defined. Any use in men is off-label and based on a provider’s clinical judgment. Dr. Houman discusses this status openly so that the decision is fully informed rather than driven by marketing.
How It’s Used and What to Expect
The FDA-approved form of bremelanotide is a subcutaneous injection, self-administered with a small autoinjector at least 45 minutes before anticipated sexual activity. It is used as needed rather than on a daily schedule, with no more than one dose in any 24-hour period and a limit on how often it’s used in a month. Dr. Houman provides instruction on proper use and sets clear, realistic expectations about what it can and cannot do.
Side Effects and Safety
Bremelanotide does have side effects worth understanding. The most common is nausea, which affects a large share of users — particularly with the first dose — along with flushing, headache, and reactions at the injection site. Importantly, it causes a temporary rise in blood pressure and a dip in heart rate after each dose, usually resolving within about 12 hours. For that reason, it should not be used by men with uncontrolled high blood pressure or known cardiovascular disease. With repeated use, it can also cause darkening of the skin or gums. Dr. Houman reviews your health history carefully to determine whether it’s a safe option for you.
Is Bremelanotide Right for You?
Bremelanotide is rarely a first step. Because low desire usually has an identifiable cause, Dr. Houman generally looks for and addresses those causes — such as low testosterone or a contributing medication — before considering an off-label medication. For some men with persistent low desire that hasn’t responded to other measures, it may be worth a careful, fully informed conversation. A thorough evaluation, including your cardiovascular health, determines whether it’s an appropriate option.
Frequently Asked Questions About Bremelanotide for Men
-
No — bremelanotide (Vyleesi) is FDA-approved only for premenopausal women with low sexual desire; its use in men is off-label, and dedicated studies establishing its safety and effectiveness in men are lacking.
-
ED medications like sildenafil work on blood flow to produce an erection, while bremelanotide acts on the brain’s desire pathways to increase sexual interest — they address different parts of sexual function.
-
The FDA-approved form is a subcutaneous injection given about 45 minutes before sexual activity, used as needed rather than on a daily schedule.
-
The most common is nausea, especially with the first dose, along with flushing, headache, and injection-site reactions; it also causes a temporary rise in blood pressure.
-
It shouldn’t be used by men with uncontrolled high blood pressure or known cardiovascular disease, given its temporary effect on blood pressure and heart rate.
-
Usually, yes — Dr. Houman typically looks for and addresses underlying causes of low desire, such as low testosterone, before considering an off-label medication like bremelanotide.
Why Choose Dr. Houman for Bremelanotide in Los Angeles
- Honest Off-Label Guidance: A clear explanation of FDA status and the limits of the evidence in men.
- Cause-First Approach: Underlying drivers of low desire addressed before off-label options.
- Careful Safety Screening: Cardiovascular and health history reviewed before any use.
- Subspecialty Sexual Medicine Expertise: Fellowship-trained judgment behind every recommendation.
Meet Dr. Houman
Expert in Men’s Health with Tower Urology and Cedars Sinai
Dr. Justin Houman, MD, FACS is a board-certified urologist and fellowship-trained microsurgeon at Tower Urology, Cedars-Sinai Medical Center in Los Angeles. His subspecialty training in male reproductive medicine and microsurgery is held by fewer than 2% of practicing urologists in the United States.
His clinical focus is narrow by design. Varicoceles, chronic testicular pain, male infertility, vasectomy, testosterone optimization, erectile dysfunction, penile implant surgery, and Peyronie’s disease are not add-on services here. They are the practice. Patients travel from across the country and internationally for procedures, particularly microsurgical varicocelectomy, spermatic cord denervation, and inflatable penile implant surgery, that require a level of subspecialty training and surgical volume most urology practices do not have.
Bremelanotide (PT-141) Consultations in Los Angeles
If low desire has persisted despite addressing the usual causes, bremelanotide may be worth an honest, informed conversation — one that’s clear about both its potential and its off-label status. Dr. Houman offers candid, evidence-based consultations for men across Los Angeles and Southern California. Contact the Los Angeles office to schedule a consultation and discuss whether it’s a reasonable option for you.
